King's Health Questionnaire (KHQ)

DIAGNOSTIC_TEST2 trials

Sponsors

GlaxoSmithKline, Cardenal Herrera University

Conditions

Stress Urinary IncontinenceUrinary Bladder, Overactive

Phase 3

Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder

CompletedNCT02820844

GlaxoSmithKlineUrinary Bladder, Overactive

Start: 2016-08-10End: 2018-11-12Updated: 2020-11-27

Unknown Phase

Second-generation Radiofrequency Application and Therapeutic Exercise for Stress Urinary Incontinence

CompletedNCT07095283

Cardenal Herrera UniversityStress Urinary Incontinence

Start: 2025-08-01End: 2025-09-30Updated: 2026-02-10

Related Papers

Efficacy and safety of onabotulinumtoxinA in patients with overactive bladder: subgroup analyses by sex and by serum prostate-specific antigen levels in men from a randomized controlled trial

International Urology and Nephrology2021-07-227 citations